Sedation Awakening for Critical Illness
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores the impact of daily awakening of sedated patients on the medication required to maintain stable blood pressure in the ICU. It focuses on patients who need mechanical ventilation and medication for shock. Participants must be on a ventilator with sedation and require medication through a central line for shock, but they must not be using the sedative dexmedetomidine. As an unphased trial, this study provides patients the opportunity to contribute to important research that could enhance ICU care practices.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop your current medications, but you cannot participate if you are taking Dexmedetomidine as a sedative.
What prior data suggests that this protocol is safe for ICU patients?
Research has shown that the level of sedation in very sick adults does not increase the risk of death, confusion, or other serious side effects. Studies have also found that taking breaks from sedation can help patients spend less time on breathing machines and leave the ICU sooner. Specifically, one study found that combining sedation breaks with breathing exercises reduced the number of days patients needed help to breathe.
Overall, sedation breaks are generally well-tolerated, meaning patients usually handle them without serious problems. It is important to know that prolonged sedation can lead to more time on breathing machines and increase the risk of lung infections and confusion. Therefore, careful management of sedation is crucial for safety and recovery.12345Why are researchers excited about this trial?
Researchers are excited about the Sedation Awakening Trial (SAT) because it aims to improve outcomes for ICU patients undergoing mechanical ventilation while requiring vasoactive drug infusions for shock. Unlike the traditional continuous sedation methods, SAT involves periodically stopping sedation to assess a patient's neurological status, potentially reducing ventilation duration and improving recovery times. This approach is different because it balances the need for sedation with the benefits of reducing sedative exposure, which could enhance patient outcomes and reduce ICU stays.
What evidence suggests that daily awakening from sedation is effective in reducing vasoactive medication in ICU patients?
Research shows that waking ICU patients on ventilators daily, a process called Sedation Awakening Trials, can lead to better outcomes. In this trial, participants will undergo Sedation Awakening Trials as part of their treatment. Studies have found that these trials can shorten the time patients need mechanical ventilation and reduce their stay in the ICU. Additionally, maintaining lighter sedation levels might decrease the risk of death in critically ill patients by 25%. Evidence also indicates that these trials can result in fewer complications and less mental impairment. Overall, these trials have been linked to better recovery and fewer problems related to sedation.26789
Who Is on the Research Team?
John Kress, MD
Principal Investigator
University of Chicago
Are You a Good Fit for This Trial?
Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Observation
Observation of mean arterial pressure and vasoactive drug dose before and during the awakening from sedation trial
Follow-up
Participants are monitored for safety and effectiveness after the observation period
What Are the Treatments Tested in This Trial?
Interventions
- Sedation Awakening Trial
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor